Dynesys Spinal System Post Market 522 Study
Post Market Surveillance for the Dynesys Spinal System, Assessing Safety and Fusion.
Sponsor: Zimmer Biomet
Terminated
Terminated at request of FDA
A NA clinical study on Degenerative Spondylolisthesis and Pseudoarthrosis, this trial is terminated or withdrawn. The trial is conducted by Zimmer Biomet and has accumulated 10 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Feb 2019 — Feb 2020 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Unknown Status NA
-
Mar 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2017 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .